# Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia

> **NCT02610400** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 9845 (actual)

## Conditions studied

- Malaria

## Interventions

- **COMBINATION_PRODUCT:** RACD
- **COMBINATION_PRODUCT:** RAVC
- **COMBINATION_PRODUCT:** rfMDA

## Key facts

- **NCT ID:** NCT02610400
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 9845 (ACTUAL)
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02610400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02610400, "Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02610400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*